The MedTech Landspace – What Next For This Newly Disrupted Sector?

The MedTech industry historically has been one of the more stable sectors. But, with multiple disruptive forces now at play, no one is immune. While some disruptions may have a more profound effect from one industry to another, any company that relies on an effective supply chain is experiencing unprecedented levels of interruption.

Supply chain disruption has shifted from a pandemic-induced situation to a much more persistent disruption, and MedTech companies must now think differently when facing the challenge of re-engineering their supply chains. Greater resilience is required to manage the unpredictability of the modern, efficiency-driven global network that has become the norm over the last 20 years. Failure to do so will make it difficult to arrest the obvious declines in growth that companies across the sector are experiencing.